For patients with chronic prostatitis and chronic pelvic pain syndrome, we commonly prescribe antibiotics, anti-inflammatory drugs and/or alpha-blockers. Yet the preponderance of evidence indicates these therapies are not consistently effective. So where do we go from here, furthering our understanding of this condition to allow for the development of more effective therapies? Dr. J. Curtis Nickel, professor in the department of urology at Queen's University in Kingston, Ontario, Canada, looks at this question with host Dr. Larry Kaskel. Dr. Nickel explains a range of criteria used to identify patients who will respond to one of the currently available therapies. He will also take a moment to emphasize the proper steps to ensure detection of chronic bacterial prostatitis.